Fractionated CO2 Laser With and Without Clobetasol for Treatment of Vulvar Lichen Sclerosus
Public ClinicalTrials.gov record NCT04951206. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Controlled Trial of Vulvar Fractionated CO2-Laser Therapy With and Without Concomitant Topical Clobetasol Propionate 0.05% Ointment for Treatment of Vulvar Lichen Sclerosus
Study identification
- NCT ID
- NCT04951206
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Medstar Health Research Institute
- Other
- Enrollment
- 212 participants
Conditions and interventions
Conditions
Interventions
- Fractionated CO2-laser Device
- Clobetasol Propionate 0.05% Ointment Drug
Device · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2022
- Primary completion
- Apr 24, 2025
- Completion
- Apr 24, 2025
- Last update posted
- Jun 4, 2025
2022 – 2025
United States locations
- U.S. sites
- 10
- U.S. states
- 10
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente - Southern California Permanente Medical Group | San Diego | California | 92110 | — |
| MedStar Health | Washington D.C. | District of Columbia | 20036 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Walter Reed National Military Medical Center | Bethesda | Maryland | 20814 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| The University of New Mexico | Albuquerque | New Mexico | 87106 | — |
| Columbia University | New York | New York | 10032 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| The Institute for Female Pelvic Medicine & Reconstructive Surgery | Allentown | Pennsylvania | 18103 | — |
| Waukesha Memorial Hospital | Waukesha | Wisconsin | 53188 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04951206, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 4, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04951206 live on ClinicalTrials.gov.